Structural abnormalities do not explain the early functional abnormalities in the peripheral nerves of the streptozotocin diabetic rat

David Walker, Anne Carrington, Susan A. Cannan, Diane Sawicki, Janet Sredy, Andrew J M Boulton, Rayaz Malik

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The streptozotocin (STZ)-diabetic rat, the most commonly employed model of experimental diabetic neuropathy, is characterised by a reduction in nerve conduction velocity, pain threshold and blood flow. Whether or not structural abnormalities underlie these functional abnormalities is unclear. 10 adult male Sprague-Dawley STZ-diabetic rats (diabetes duration 27 d) and 10 age-matched (23 wk) control animals were studied. Motor nerve conduction velocity (m s-1) was significantly reduced in diabetic (41.31 ± 0.8) compared with control (46.15 ± 1.5) animals (P < 0.001). The concentration of sciatic nerve glucose (P < 0.001), fructose (P < 0.001) and sorbitol (P < 0.001) was elevated, and myoinositol (P < 0.001) was reduced in diabetic compared with control animals. Detailed morphometric studies demonstrated no significant difference in fascicular area, myelinated fibre density, fibre and axon areas as well as unmyelinated fibre density and diameter. Endoneurial capillary density, basement membrane area and endothelial cell profile number did not differ between diabetic and control animals. However, luminal area (P < 0.03) was increased and endothelial cell area (P < 0.08) was decreased in the diabetic rats. We conclude there is no detectable structural basis for the reduction in nerve conduction velocity, pain threshold or blood flow, observed in the streptozotocin diabetic rat.

Original languageEnglish
Pages (from-to)419-427
Number of pages9
JournalJournal of Anatomy
Volume195
Issue number3
DOIs
Publication statusPublished - Oct 1999
Externally publishedYes

Fingerprint

peripheral nerves
streptozotocin
Streptozocin
abnormality
Peripheral Nerves
Neural Conduction
nerve tissue
Pain Threshold
animal
rats
blood flow
endothelial cells
pain
animals
Endothelial Cells
blood
diabetic neuropathy
Sorbitol
Diabetic Neuropathies
diabetes

Keywords

  • Diabetes mellitus
  • Microangiopathy
  • Morphometry
  • Nerve conduction velocity
  • Peripheral neuropathy

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Anatomy

Cite this

Structural abnormalities do not explain the early functional abnormalities in the peripheral nerves of the streptozotocin diabetic rat. / Walker, David; Carrington, Anne; Cannan, Susan A.; Sawicki, Diane; Sredy, Janet; Boulton, Andrew J M; Malik, Rayaz.

In: Journal of Anatomy, Vol. 195, No. 3, 10.1999, p. 419-427.

Research output: Contribution to journalArticle

Walker, David ; Carrington, Anne ; Cannan, Susan A. ; Sawicki, Diane ; Sredy, Janet ; Boulton, Andrew J M ; Malik, Rayaz. / Structural abnormalities do not explain the early functional abnormalities in the peripheral nerves of the streptozotocin diabetic rat. In: Journal of Anatomy. 1999 ; Vol. 195, No. 3. pp. 419-427.
@article{5b249f3ded1e4a03ad8ce14ac87fdd23,
title = "Structural abnormalities do not explain the early functional abnormalities in the peripheral nerves of the streptozotocin diabetic rat",
abstract = "The streptozotocin (STZ)-diabetic rat, the most commonly employed model of experimental diabetic neuropathy, is characterised by a reduction in nerve conduction velocity, pain threshold and blood flow. Whether or not structural abnormalities underlie these functional abnormalities is unclear. 10 adult male Sprague-Dawley STZ-diabetic rats (diabetes duration 27 d) and 10 age-matched (23 wk) control animals were studied. Motor nerve conduction velocity (m s-1) was significantly reduced in diabetic (41.31 ± 0.8) compared with control (46.15 ± 1.5) animals (P < 0.001). The concentration of sciatic nerve glucose (P < 0.001), fructose (P < 0.001) and sorbitol (P < 0.001) was elevated, and myoinositol (P < 0.001) was reduced in diabetic compared with control animals. Detailed morphometric studies demonstrated no significant difference in fascicular area, myelinated fibre density, fibre and axon areas as well as unmyelinated fibre density and diameter. Endoneurial capillary density, basement membrane area and endothelial cell profile number did not differ between diabetic and control animals. However, luminal area (P < 0.03) was increased and endothelial cell area (P < 0.08) was decreased in the diabetic rats. We conclude there is no detectable structural basis for the reduction in nerve conduction velocity, pain threshold or blood flow, observed in the streptozotocin diabetic rat.",
keywords = "Diabetes mellitus, Microangiopathy, Morphometry, Nerve conduction velocity, Peripheral neuropathy",
author = "David Walker and Anne Carrington and Cannan, {Susan A.} and Diane Sawicki and Janet Sredy and Boulton, {Andrew J M} and Rayaz Malik",
year = "1999",
month = "10",
doi = "10.1017/S002187829900549X",
language = "English",
volume = "195",
pages = "419--427",
journal = "Journal of Anatomy",
issn = "0021-8782",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Structural abnormalities do not explain the early functional abnormalities in the peripheral nerves of the streptozotocin diabetic rat

AU - Walker, David

AU - Carrington, Anne

AU - Cannan, Susan A.

AU - Sawicki, Diane

AU - Sredy, Janet

AU - Boulton, Andrew J M

AU - Malik, Rayaz

PY - 1999/10

Y1 - 1999/10

N2 - The streptozotocin (STZ)-diabetic rat, the most commonly employed model of experimental diabetic neuropathy, is characterised by a reduction in nerve conduction velocity, pain threshold and blood flow. Whether or not structural abnormalities underlie these functional abnormalities is unclear. 10 adult male Sprague-Dawley STZ-diabetic rats (diabetes duration 27 d) and 10 age-matched (23 wk) control animals were studied. Motor nerve conduction velocity (m s-1) was significantly reduced in diabetic (41.31 ± 0.8) compared with control (46.15 ± 1.5) animals (P < 0.001). The concentration of sciatic nerve glucose (P < 0.001), fructose (P < 0.001) and sorbitol (P < 0.001) was elevated, and myoinositol (P < 0.001) was reduced in diabetic compared with control animals. Detailed morphometric studies demonstrated no significant difference in fascicular area, myelinated fibre density, fibre and axon areas as well as unmyelinated fibre density and diameter. Endoneurial capillary density, basement membrane area and endothelial cell profile number did not differ between diabetic and control animals. However, luminal area (P < 0.03) was increased and endothelial cell area (P < 0.08) was decreased in the diabetic rats. We conclude there is no detectable structural basis for the reduction in nerve conduction velocity, pain threshold or blood flow, observed in the streptozotocin diabetic rat.

AB - The streptozotocin (STZ)-diabetic rat, the most commonly employed model of experimental diabetic neuropathy, is characterised by a reduction in nerve conduction velocity, pain threshold and blood flow. Whether or not structural abnormalities underlie these functional abnormalities is unclear. 10 adult male Sprague-Dawley STZ-diabetic rats (diabetes duration 27 d) and 10 age-matched (23 wk) control animals were studied. Motor nerve conduction velocity (m s-1) was significantly reduced in diabetic (41.31 ± 0.8) compared with control (46.15 ± 1.5) animals (P < 0.001). The concentration of sciatic nerve glucose (P < 0.001), fructose (P < 0.001) and sorbitol (P < 0.001) was elevated, and myoinositol (P < 0.001) was reduced in diabetic compared with control animals. Detailed morphometric studies demonstrated no significant difference in fascicular area, myelinated fibre density, fibre and axon areas as well as unmyelinated fibre density and diameter. Endoneurial capillary density, basement membrane area and endothelial cell profile number did not differ between diabetic and control animals. However, luminal area (P < 0.03) was increased and endothelial cell area (P < 0.08) was decreased in the diabetic rats. We conclude there is no detectable structural basis for the reduction in nerve conduction velocity, pain threshold or blood flow, observed in the streptozotocin diabetic rat.

KW - Diabetes mellitus

KW - Microangiopathy

KW - Morphometry

KW - Nerve conduction velocity

KW - Peripheral neuropathy

UR - http://www.scopus.com/inward/record.url?scp=0032756906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032756906&partnerID=8YFLogxK

U2 - 10.1017/S002187829900549X

DO - 10.1017/S002187829900549X

M3 - Article

C2 - 10580857

AN - SCOPUS:0032756906

VL - 195

SP - 419

EP - 427

JO - Journal of Anatomy

JF - Journal of Anatomy

SN - 0021-8782

IS - 3

ER -